Autolus Therapeutics (AUTL) Receivables - Net (2022 - 2025)
Autolus Therapeutics (AUTL) has disclosed Receivables - Net for 4 consecutive years, with $32.6 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Receivables - Net changed N/A year-over-year to $32.6 million, compared with a TTM value of $32.6 million through Sep 2025, changed N/A, and an annual FY2024 reading of $15000.0, down 86.24% over the prior year.
- Receivables - Net was $32.6 million for Q3 2025 at Autolus Therapeutics, up from $26.6 million in the prior quarter.
- Across five years, Receivables - Net topped out at $32.6 million in Q3 2025 and bottomed at $15000.0 in Q4 2024.
- Average Receivables - Net over 4 years is $10.6 million, with a median of $165000.0 recorded in 2023.
- The sharpest move saw Receivables - Net dropped 9.92% in 2023, then crashed 86.24% in 2024.
- Year by year, Receivables - Net stood at $121000.0 in 2022, then decreased by 9.92% to $109000.0 in 2023, then plummeted by 86.24% to $15000.0 in 2024, then soared by 217260.0% to $32.6 million in 2025.
- Business Quant data shows Receivables - Net for AUTL at $32.6 million in Q3 2025, $26.6 million in Q2 2025, and $14.3 million in Q1 2025.